Efficacy and Safety of Baricitinib in Oral Lichen Planus: a Proof-of-Concept Study
Efficacy and Safety of Baricitinib in Oral Lichen Planus: a Proof-of-Concept Study
Active, not recruiting · NCT06158113 · Registry updated 2026-09-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Baricitinib in Oral Lichen Planus: a Proof-of-Concept Study | Lichenoid Eruptions, Mucosal Lichen Planus, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, Stomatognathic Diseases, lichen planus, lichen planus, oral, mouth disorder, skin disorder | Active, not recruiting | Phase 2 | 2026-09-01 | NCT06158113 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eli Lilly and Company | 370 |
| University of North Carolina, Chapel Hill | 249 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| UNC Dermatology and Skin Cancer Center | Chapel Hill | United States | 3 |